September 2019 – Vascular Awareness Month

September 2019 is Vascular Awareness Month. Find out more about the market outlook. We are offering 20% discount on the following Vascular Reports. Use discount code: Vascular20 at checkout to receive the discount

Related Reports

Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the implantable cardioverter defibrillator (ICD) products market. Types of cardiac defibrillators covered by the scope of this report include ICDs, subcutaneous ICDs (S-ICDs), and cardiac resynchronization therapy-defibrillators (CRT-Ds).

The combined global market for ICD devices totals nearly $8bn, and is expected to climb at a CAGR of 4.4% through 2023. The most influential driver of the global ICDs market is the increasing prevalence of cardiovascular disease (CVD) as a result of the expanding geriatric population and an increasing prevalence of CVD risk factors such as obesity and diabetes.

Overview

Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the implantable pacemaker products market. Implantable pacemaker products covered by this report include:

  • single-chamber pacemakers, including leadless pacemakers
  • dual-chamber pacemakers
  • biventricular pacemakers, also known as cardiac resynchronization therapy pacemakers (CRT-P)

This Market Spotlight report covers the coronary artery disease market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, probability of success, patent information, 10-year disease prevalence and incidence forecasts, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.

This Market Spotlight report covers the Systemic Hypertension market, comprising key marketed and pipeline drugs, clinical trials, key upcoming and regulatory events, probability of success, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.